Martino Ambrosini - Concepedia

Concepedia

Author

Martino Ambrosini

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

M. Ambrosini, M.Theresa Ambrosini, Martino Ambrosini

38

Publications

1.5K

Citations

21

H-Index

49

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Utrecht University Amsterdam University Medical Centers University of Twente

MA

About

Martino Ambrosini is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	836
2	Engineering	3	3	157
3	Natural Sciences	1	1	14
4	Biochemistry	1	1	14
5	Biomedical Engineering	1	1	58

Martino Ambrosini

×

25

Publications

1.5K

Citations

21

H-Index

	Year	Citations
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells Maurizio Perdicchio, Juan M. Ilarregui, Marleen I. Verstege, Proceedings of the National Academy of Sciences Adaptive Immune SystemT-regulatory CellImmunologyImmune RegulationImmunodominance	2016	181
Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells Wendy W. J. Unger, Astrid J. van Beelen, Sven C. M. Bruijns, Journal of Controlled Release Cancer ImmunosurveillanceCd8+ T-cell ResponsesImmunologyGlycan-modified LiposomesAutoimmunity	2012	176
Glycan modification of glioblastoma‐derived extracellular vesicles enhances receptor‐mediated targeting of dendritic cells Sophie A. Dusoswa, Sophie K. Horrevorts, Martino Ambrosini, Journal of Extracellular Vesicles	2019	110
Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells Juan J. García‐Vallejo, Martino Ambrosini, Annemieke Overbeek, Molecular Immunology Cell-based Drug DeliveryNanomedicineMultivalent Glycopeptide DendrimersEngineeringTargeted Delivery	2012	109
CNS myelin induces regulatory functions of DC-SIGN–expressing, antigen-presenting cells via cognate interaction with MOG Juan J. García‐Vallejo, Juan M. Ilarregui, Hakan Kalay, The Journal of Experimental Medicine	2014	107
Selective tumor antigen vaccine delivery to human CD169 <sup>+</sup> antigen-presenting cells using ganglioside-liposomes Alsya J. Affandi, Joanna Grabowska, Katarzyna Olesek, Proceedings of the National Academy of Sciences	2020	82
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens Cynthia M. Fehres, Hakan Kalay, Sven C. M. Bruijns, Journal of Controlled Release Immunocytochemical TechniqueImmunologyTherapeutic VaccineDifferent FormulationsAntibody Engineering	2015	75
MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses Martine A. Boks, Martino Ambrosini, Sven C. M. Bruijns, Journal of Controlled Release ImmunologyImmune Checkpoint InhibitorTumor TargetingMpla IncorporationImmunotherapy	2015	68
Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets Sanne Duinkerken, Sophie K. Horrevorts, Hakan Kalay, Theranostics	2019	66
Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells Juan J. García‐Vallejo, Nathalie Koning, Martino Ambrosini, International Immunology	2013	60

Page 1